Literature DB >> 16199015

Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder.

Kai G Kahl1, Susanne Bens, Kristin Ziegler, Sebastian Rudolf, Leif Dibbelt, Andreas Kordon, Ulrich Schweiger.   

Abstract

BACKGROUND: Major depression in young women is often comorbid with borderline personality disorder (BPD); however, adrenal steroids and pro-inflammatory cytokines in patients with comorbid current major depressive disorder and BPD (MDD/BPD) have not been systematically examined. Therefore, our study aimed at examining serum profiles of cortisol, cytokines, and the cortisol/dehydroepiandrosterone (cortisol/DHEA) ratio in MDD/BPD patients and a healthy comparison group.
METHODS: Twelve medication-free female patients with MDD/BPD and 12 healthy women were included. Serum profiles of cortisol, DHEA, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta were sampled, and the molar cortisol/DHEA ratio was determined.
RESULTS: Concentrations of serum cortisol, TNF-alpha, and IL-6, as well as the cortisol/DHEA ratios were significantly increased in MDD/BPD patients as compared with the healthy comparison group.
CONCLUSIONS: Depressed patients with comorbid BPD display endocrine and immune alterations similar to those observed in cases of melancholic MDD without BPD. Elevated concentrations of serum cortisol, cortisol/DHEA ratios, and pro-inflammatory cytokines might indicate a state marker in these patients and might contribute to long-term metabolic alterations that have also been associated with MDD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199015     DOI: 10.1016/j.biopsych.2005.08.001

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  18 in total

1.  Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study.

Authors:  Kai G Kahl; Wiebke Greggersen; Ulrich Schweiger; Joachim Cordes; Christoph U Correll; Helge Frieling; Chakrapani Balijepalli; Christian Lösch; Susanne Moebus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-07-10       Impact factor: 5.270

2.  A Systematic Review of Personality Disorders and Health Outcomes.

Authors:  Katherine L Dixon-Gordon; Diana J Whalen; Brianne K Layden; Alexander L Chapman
Journal:  Can Psychol       Date:  2015-10-15

Review 3.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

Review 4.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

5.  Diurnal patterns of salivary cortisol and DHEA using a novel collection device: electronic monitoring confirms accurate recording of collection time using this device.

Authors:  Mark L Laudenslager; Jacqueline Calderone; Sam Philips; Crystal Natvig; Nichole E Carlson
Journal:  Psychoneuroendocrinology       Date:  2013-03-13       Impact factor: 4.905

Review 6.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 7.  Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

Authors:  Andrew H Miller; Ebrahim Haroon; Charles L Raison; Jennifer C Felger
Journal:  Depress Anxiety       Date:  2013-03-06       Impact factor: 6.505

Review 8.  Glial biomarkers in human central nervous system disease.

Authors:  Gwenn A Garden; Brian M Campbell
Journal:  Glia       Date:  2016-05-26       Impact factor: 7.452

Review 9.  Inflammation: a mechanism of depression?

Authors:  Qiu-Qin Han; Jin Yu
Journal:  Neurosci Bull       Date:  2014-05-16       Impact factor: 5.203

Review 10.  Suggested Biomarkers for Major Depressive Disorder.

Authors:  Yunus Hacimusalar; Ertuğrul Eşel
Journal:  Noro Psikiyatr Ars       Date:  2018-05-28       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.